Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Becton, Dickinson and Company

Market Cap 40.6B 35.1B 32.33B 30.29B 56.79B 3,861B 57.65B 383B 149B 1,878B 152B 149B 6,504B P/E Ratio 2026 *
36.4x
P/E Ratio 2027 * 28.1x
Enterprise Value 56.56B 48.89B 45.04B 42.19B 79.1B 5,378B 80.3B 534B 207B 2,616B 212B 208B 9,059B EV / Sales 2026 *
2.94x
EV / Sales 2027 * 2.77x
Free-Float
74.04%
Yield 2026 *
2.63%
Yield 2027 * 2.68%
1 day-0.75%
1 week-2.22%
Current month-0.60%
1 month+2.16%
3 months-10.38%
6 months-27.04%
Current year-24.65%
1 week 144.4
Extreme 144.4
152.55
1 month 141.82
Extreme 141.8201
153.24
Current year 141.82
Extreme 141.8201
213.08
1 year 141.82
Extreme 141.8201
213.08
3 years 141.82
Extreme 141.8201
287.32
5 years 141.82
Extreme 141.8201
287.32
10 years 141.82
Extreme 141.8201
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap.
05-31Fiscal year

Chief Executive Officer

60,627 0.0220%
05-31Free

Executive/Senior Manager

14,258 0.0052%
05-31Other

Executive/Senior Manager

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-2.22%-15.33%-41.85% 40.6B
-1.64%-2.86%-34.82%-13.29% 156B
-0.16%-2.11%-8.93%-4.22% 103B
+0.07%+4.20%-1.73%+58.05% 54.77B
+3.00%-0.04%+54.23%+54.37% 53.52B
-1.40%+6.27% - - 31.4B
+0.16%+3.83%-9.18%-39.38% 29.04B
-0.46%+3.62%+46.79%-5.59% 23.34B
-2.85%-3.36%-17.02%-0.74% 20.81B
+0.16%-2.21%-13.78%+0.28% 20.23B
Average -0.21%+1.22%+0.03%+0.85% 53.3B
Weighted average by Cap. +0.05%+0.29%-7.93%+1.19%

Financials

2026 *2027 *
Net sales 19.21B 16.6B 15.3B 14.33B 26.86B 1,826B 27.27B 181B 70.41B 888B 72.07B 70.54B 3,076B 19.71B 17.04B 15.7B 14.7B 27.57B 1,874B 27.99B 186B 72.26B 912B 73.97B 72.39B 3,157B
Net income 1.12B 972M 896M 839M 1.57B 107B 1.6B 10.61B 4.12B 52.03B 4.22B 4.13B 180B 1.45B 1.25B 1.15B 1.08B 2.03B 138B 2.06B 13.68B 5.31B 67.04B 5.44B 5.32B 232B
Net Debt 15.95B 13.79B 12.71B 11.9B 22.32B 1,517B 22.65B 151B 58.49B 738B 59.88B 58.6B 2,556B 14.07B 12.17B 11.21B 10.5B 19.68B 1,338B 19.98B 133B 51.59B 651B 52.81B 51.68B 2,254B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-06-12 146.24 $ -0.75% 1,958,861
26-06-11 147.35 $ -0.30% 1,639,985
26-06-10 147.79 $ -2.80% 1,747,951
26-06-09 152.04 $ +1.37% 2,214,895
26-06-08 149.99 $ -0.77% 1,925,969
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
146.24USD
Average target price
180.69USD
Spread / Average Target
+23.56%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!